PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
AMAM vs. PLTR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

AMAM vs. PLTR

Last updated May 18, 2025

Compare and contrast key facts about Ambrx Biopharma Inc. (AMAM) and Palantir Technologies Inc. (PLTR).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMAM or PLTR.

Correlation

The correlation between AMAM and PLTR is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AMAM vs. PLTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ambrx Biopharma Inc. (AMAM) and Palantir Technologies Inc. (PLTR). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Fundamentals

Market Cap

AMAM:

$1.77B

PLTR:

$305.66B

EPS

AMAM:

$0.42

PLTR:

$0.23

PE Ratio

AMAM:

66.67

PLTR:

563.13

PS Ratio

AMAM:

432.96

PLTR:

98.12

PB Ratio

AMAM:

7.31

PLTR:

56.35

Returns By Period

AMAM

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

PLTR

YTD

71.25%

1M

38.11%

6M

96.93%

1Y

495.22%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

AMAM vs. PLTR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
AMAM
The Risk-Adjusted Performance Rank of AMAM is 9494
Overall Rank
The Sharpe Ratio Rank of AMAM is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of AMAM is 9494
Sortino Ratio Rank
The Omega Ratio Rank of AMAM is 9494
Omega Ratio Rank
The Calmar Ratio Rank of AMAM is 9797
Calmar Ratio Rank
The Martin Ratio Rank of AMAM is 9393
Martin Ratio Rank
PLTR
The Risk-Adjusted Performance Rank of PLTR is 9999
Overall Rank
The Sharpe Ratio Rank of PLTR is 100100
Sharpe Ratio Rank
The Sortino Ratio Rank of PLTR is 9999
Sortino Ratio Rank
The Omega Ratio Rank of PLTR is 9898
Omega Ratio Rank
The Calmar Ratio Rank of PLTR is 100100
Calmar Ratio Rank
The Martin Ratio Rank of PLTR is 100100
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AMAM vs. PLTR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ambrx Biopharma Inc. (AMAM) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

No data
No data
No data
No data

Loading data...

Dividends

AMAM vs. PLTR - Dividend Comparison

Neither AMAM nor PLTR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

AMAM vs. PLTR - Drawdown Comparison

Loading data...

Volatility

AMAM vs. PLTR - Volatility Comparison

Loading data...

Financials

AMAM vs. PLTR - Financials Comparison

This section allows you to compare key financial metrics between Ambrx Biopharma Inc. and Palantir Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.00200.00M400.00M600.00M800.00M20212022202320242025
53.00K
883.86M
(AMAM) Total Revenue
(PLTR) Total Revenue
Values in USD except per share items